INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2011
Total net assets |
£97.7m |
NAV per share |
175.9p |
Share price |
151.0p |
Total value of unquoted investments |
£18.3m |
Total number of portfolio companies |
69 |
Cash |
2% NAV |
Cash committed and reserved to unquoted investments |
(9)% NAV |
Portfolio companies with < 1 year of cash |
13% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
5.6 |
Gilead Sciences |
5.4 |
Teva |
4.7 |
Micromet |
4.2 |
Insulet |
4.1 |
Shire |
3.5 |
Celgene |
3.3 |
EUSA |
3.0 |
Aptiv |
2.9 |
Pharmaxis |
2.9 |
|
----------- |
Total |
39.6 |
Geographical Allocation |
% |
United States |
74 |
Europe |
16 |
Israel |
5 |
Australia |
3 |
Cash |
2 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
79 |
Unquoted |
19 |
Cash |
2 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
13 DECEMBER 2011